Published in Clinics (Sao Paulo) on January 01, 2011
Inhibition of placental growth factor improves surgical outcome of glaucoma surgery. J Cell Mol Med (2013) 0.82
Mesenchymal stem cells improve healing of the cornea after alkali injury. Graefes Arch Clin Exp Ophthalmol (2015) 0.76
Wound Healing Modulation in Glaucoma Filtration Surgery- Conventional Practices and New Perspectives: Antivascular Endothelial Growth Factor and Novel Agents (Part II). J Curr Glaucoma Pract (2014) 0.75
Anti-Vascular Endothelial Growth Factor (Bevacizumab) Therapy Reduces Hypertrophic Scar Formation in a Rabbit Ear Wounding Model. Arch Plast Surg (2016) 0.75
Corneal neovascularization. Curr Opin Ophthalmol (2001) 3.22
Expression of vascular endothelial growth factor and its receptors in inflamed and vascularized human corneas. Invest Ophthalmol Vis Sci (2000) 1.71
Anti-VEGF agents in the treatment of neovascular age-related macular degeneration: applying clinical trial results to the treatment of everyday patients. Am J Ophthalmol (2007) 1.65
Bevacizumab inhibits corneal neovascularization in an alkali burn induced model of corneal angiogenesis. Clin Experiment Ophthalmol (2007) 1.64
Vascular endothelial growth factor is sufficient to produce iris neovascularization and neovascular glaucoma in a nonhuman primate. Arch Ophthalmol (1996) 1.64
Safety, penetration and efficacy of topically applied bevacizumab: evaluation of eyedrops in corneal neovascularization after chemical burn. Acta Ophthalmol (2007) 1.41
Inhibition of vascular endothelial growth factor reduces scar formation after glaucoma filtration surgery. Invest Ophthalmol Vis Sci (2009) 1.40
Vitreous levels of bevacizumab and vascular endothelial growth factor-A in patients with choroidal neovascularization. Ophthalmology (2008) 1.37
Emergency treatment of chemical and thermal eye burns. Acta Ophthalmol Scand (2002) 1.21
Inhibition of corneal neovascularization by subconjunctival bevacizumab in an animal model. Am J Ophthalmol (2008) 1.19
Bevacizumab (Avastin) eye drops inhibit corneal neovascularization. Graefes Arch Clin Exp Ophthalmol (2007) 1.15
Bevacizumab application delays epithelial healing in rabbit cornea. Invest Ophthalmol Vis Sci (2009) 1.14
Vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in the regulation of corneal neovascularization and wound healing. Acta Ophthalmol Scand (2004) 1.13
Inhibition of corneal neovascularization by topical bevacizumab (Anti-VEGF) and Sunitinib (Anti-VEGF and Anti-PDGF) in an animal model. Am J Ophthalmol (2010) 0.97
Evaluation of cytotoxic effects of bevacizumab on human corneal cells. Cornea (2009) 0.95
Ocular angiogenesis: the role of growth factors. Acta Ophthalmol Scand (2006) 0.94
Anti-VEGF monoclonal antibody-induced regression of corneal neovascularization and inflammation in a rabbit model of herpetic stromal keratitis. Graefes Arch Clin Exp Ophthalmol (2009) 0.93
The effect of subconjuctival combined treatment of bevacizumab and triamcinolone acetonide on corneal neovascularization in rabbits. Cornea (2010) 0.87
Effect of subconjunctival bevacizumab (Avastin) on experimental corneal neovascularization in guinea pigs. Cornea (2008) 0.87
Opinions on risk factors and management of corneal graft rejection in the United kingdom. Cornea (2005) 0.86
An animal model for corneal graft rejection in high-risk keratoplasty. Transplantation (1988) 0.83
Inhibition of corneal neovascularization after alkali burn: comparison of different doses of bevacizumab in monotherapy or associated with dexamethasone. Clin Experiment Ophthalmol (2010) 0.81
The effect of subconjunctival suramin on corneal neovascularization in rabbits. Cornea (2010) 0.79
Effects of topical administration of 12-methyl tetradecanoic acid (12-MTA) on the development of corneal angiogenesis. Angiogenesis (2007) 0.78
[Model of inflammatory angiogenesis in rabbit cornea induced by punctual alkaline cauterization]. Acta Cir Bras (2005) 0.77
Refractive surgical problem. December consultation #1. J Cataract Refract Surg (2013) 5.25
Refractive surgical problem: June consultation #1. J Cataract Refract Surg (2014) 5.18
Options for an eye with a thin cornea: June consultation #1. J Cataract Refract Surg (2015) 4.57
Flaporhexis: rapid and effective technique to limit epithelial ingrowth after LASIK enhancement. J Cataract Refract Surg (2011) 2.03
Corneal infections after implantation of intracorneal ring segments. Cornea (2004) 1.73
Collagen crosslinking with riboflavin and ultraviolet-A in eyes with pseudophakic bullous keratopathy. J Cataract Refract Surg (2010) 1.71
Impact of collagen crosslinking on corneal sensitivity in keratoconus patients. Cornea (2013) 1.46
[Importance of the ophthalmological evaluation in newborns]. J Pediatr (Rio J) (2003) 1.40
Influence of the reference surface shape for discriminating between normal corneas, subclinical keratoconus, and keratoconus. J Refract Surg (2013) 1.22
Screening for Keratoconus and Related Ectatic Corneal Disorders. Cornea (2015) 1.09
Topographic, corneal wavefront, and refractive outcomes 2 years after collagen crosslinking for progressive keratoconus. Cornea (2014) 1.05
Wavefront ablation profiles in refractive surgery: description, results, and limitations. J Refract Surg (2012) 1.01
Graft versus host disease: clinical evaluation, diagnosis and management. Graefes Arch Clin Exp Ophthalmol (2013) 1.00
Surgical management of presbyopia. Clin Ophthalmol (2012) 0.99
The corneal epithelial basement membrane: structure, function, and disease. Invest Ophthalmol Vis Sci (2013) 0.98
Transmission electron microscopy analysis of epithelial basement membrane repair in rabbit corneas with haze. Invest Ophthalmol Vis Sci (2013) 0.97
Peripheral sterile corneal ring infiltrate after riboflavin-UVA collagen cross-linking in keratoconus. Cornea (2012) 0.93
Efficacy and safety of travoprost 0.004%/timolol 0.5% fixed combination as transition therapy in patients previously on prostaglandin analog monotherapy. Clin Ophthalmol (2012) 0.92
Detection of subclinical keratoconus using an automated decision tree classification. Am J Ophthalmol (2013) 0.91
Effects of blue light-filtering intraocular lenses on the macula, contrast sensitivity, and color vision after a long-term follow-up. J Cataract Refract Surg (2011) 0.90
Biological and biomechanical responses to traditional epithelium-off and transepithelial riboflavin-UVA CXL techniques in rabbits. J Refract Surg (2013) 0.88
Applications of wavefront technology. J Cataract Refract Surg (2012) 0.87
Ocular findings in patients with systemic sclerosis. Clinics (Sao Paulo) (2011) 0.87
Combined esterified estrogen and methyltestosterone treatment for dry eye syndrome in postmenopausal women. Am J Ophthalmol (2005) 0.86
Corneal involvement in systemic inflammatory diseases. Eye Contact Lens (2015) 0.85
Wavefront analysis after wavefront-guided myopic LASIK using a new generation aberrometer. J Refract Surg (2014) 0.84
[Evaluation of the hydro-alcoholic Schinus terebinthifolius Raddi (Aroeira) extract in the healing process of the alba linea in rats]. Acta Cir Bras (2006) 0.84
[Treatment of trichiasis with high-frequency radio wave electrosurgery]. Arq Bras Oftalmol (2007) 0.83
[Relationship between high-order aberrations and age and between high-order aberrations and refraction errors]. Arq Bras Oftalmol (2007) 0.82
Role of percent tissue altered on ectasia after LASIK in eyes with suspicious topography. J Refract Surg (2015) 0.81
Evaluation of dry eye signs and symptoms in patients with systemic sclerosis. Graefes Arch Clin Exp Ophthalmol (2012) 0.81
Optimization of intraocular lens constant improves refractive outcomes in combined endothelial keratoplasty and cataract surgery. Ophthalmology (2012) 0.81
[Femtosecond laser versus mechanical microkeratome for LASIK flap creation]. Arq Bras Oftalmol (2014) 0.80
[Evaluation of aroeira (Schinus terebinthifolius Raddi) extract on the healing process of gastroraphy in rats]. Acta Cir Bras (2006) 0.80
[Healing process in cutaneous surgical wounds in rats under the influence of Orbignya phalerata aqueous extract]. Acta Cir Bras (2006) 0.79
Suction loss during thin-flap femto-LASIK: management and beneficial refractive effect of the epithelium. J Cataract Refract Surg (2012) 0.79
Corneal higher order aberrations after myopic wavefront-optimized ablation. J Refract Surg (2013) 0.79
Intense Early Flattening After Corneal Collagen Cross-linking. J Refract Surg (2015) 0.79
Central corneal thickness in patients with systemic sclerosis: a controlled study. Cornea (2011) 0.78
[CBO/ALCON teaching method of phacoemulsification: results of Hospital de Olhos do Paraná]. Arq Bras Oftalmol (2011) 0.78
Visual outcomes of eyes implanted with a toric multifocal intraocular lens. J Refract Surg (2014) 0.78
Response of the posterior corneal surface to myopic laser in situ keratomileusis with different ablation depths. J Cataract Refract Surg (2012) 0.78
Technique for preparation of the corneal endothelium-Descemet membrane complex for transplantation. Cornea (2006) 0.78
Modified femtosecond laser-assisted sutureless anterior lamellar keratoplasty. Cornea (2013) 0.78
[The main factors related with cornea non-donation of potential donors in a university hospital of Curitiba]. Arq Bras Oftalmol (2009) 0.78
Regeneration of Defective Epithelial Basement Membrane and Restoration of Corneal Transparency After Photorefractive Keratectomy. J Refract Surg (2017) 0.78
Intracorneal Ring Segments Implantation for Corneal Ectasia. J Refract Surg (2016) 0.77
Corneal Molecular and Cellular Biology for the Refractive Surgeon: The Critical Role of the Epithelial Basement Membrane. J Refract Surg (2016) 0.77
Accelerated Corneal Collagen Cross-linking for Postoperative LASIK Ectasia: Two-Year Outcomes. J Refract Surg (2015) 0.77
Very late-onset corneal scar triggered by trauma after photorefractive keratectomy. J Cataract Refract Surg (2012) 0.77
[Total testosterone level in postmenopausal women with dry eye]. Arq Bras Oftalmol (2007) 0.77
[Citophotometric expression of the factor of cellular proliferation ki-67 in the goiter colloid and in the papillary carcinoma of the thyroid]. Rev Col Bras Cir (2009) 0.77
Comparison of keratometric changes after myopic ablation: ray tracing versus simulated keratometry. J Refract Surg (2013) 0.77
Visual performance after toric IOL implantation in patients with corneal astigmatism. Arq Bras Oftalmol (2009) 0.77
[Psychological and social aspects of patients with keratoconus]. Arq Bras Oftalmol (2007) 0.76
Topical cyclosporine a treatment in corneal refractive surgery and patients with dry eye. J Refract Surg (2014) 0.76
Femtosecond Laser-assisted Cataract Surgery in Patients With Marfan Syndrome and Subluxated Lens. J Refract Surg (2015) 0.76
Role of optical coherence tomography on corneal surface laser ablation. J Ophthalmol (2012) 0.75
A clinical comparison between DisCoVisc and 2% hydroxypropylmethylcellulose in phacoemulsification: a fellow eye study. Clinics (Sao Paulo) (2012) 0.75
[Patients with astigmatism who underwent cataract surgery by phacoemulsification: toric IOL x asferic IOL?]. Arq Bras Oftalmol (2013) 0.75
Calcium deposits on hydrophilic acrylic intraocular lenses. J Cataract Refract Surg (2013) 0.75
[Experimental investigation of postoperative use of medication in refractive surgery]. Arq Bras Oftalmol (2005) 0.75
[Influence of corneal astigmatism in final visual acuity after implantation of AcrySof ReSTOR: case report]. Arq Bras Oftalmol (2008) 0.75
[Snellen visual acuity evaluation]. Arq Bras Oftalmol (2010) 0.75
Phototherapeutic Keratectomy: Science and Art. J Refract Surg (2017) 0.75
[Study of torsional movements in refractive surgery]. Arq Bras Oftalmol (2007) 0.75
[Amniotic membrane transplantation associated with conjunctival autograft for primary pterygium treatment]. Arq Bras Oftalmol (2005) 0.75
[Asymmetric intrastromal corneal ring for the treatment of keratoconus]. Arq Bras Oftalmol (2011) 0.75
[Technique for separating Descemet membrane for corneal endothelial cells transplantation: experimental study in rabbits]. Arq Bras Oftalmol (2010) 0.75
Significant haze after photorefractive keratectomy in a cornea with previous arcuate keratotomy: June consultation #1. J Cataract Refract Surg (2016) 0.75
Options for a young patient with considerably high, topographically stable, astigmatism: December consultation #1. J Cataract Refract Surg (2015) 0.75
[Analysis of corneal curvature alteration following intrastromal corneal ring implantation: experimental study in rabbits]. Arq Bras Oftalmol (2007) 0.75
[Experimental study of new material for biocompatibility as orbital implant]. Arq Bras Oftalmol (2013) 0.75
Longitudinal Evaluation of Central Corneal Thickness in Patients With Systemic Sclerosis. Cornea (2016) 0.75
Accelerated Corneal Cross-linking: We Must Acquire Knowledge as Fast. J Refract Surg (2016) 0.75
Corneal Cross-Linking (CXL): Standardizing Terminology and Protocol Nomenclature. J Refract Surg (2017) 0.75
Evolution Profiles of Different Corneal Parameters in Progressive Keratoconus. Cornea (2016) 0.75
Refractive surgical problem: December consultation #1. J Cataract Refract Surg (2014) 0.75
OCT Study of the Femtosecond Laser Opaque Bubble Layer. J Refract Surg (2017) 0.75
[Evaluation of the quality of donor corneas in relation to the age of donor and cause of death]. Arq Bras Oftalmol (2009) 0.75
Corneal Collagen Cross-linking in Advanced Keratoconus: A 4-Year Follow-up Study. J Refract Surg (2016) 0.75
Reply. Alterations of corneal nerve density do not translate into clinically evident corneal hyposensitivity. Cornea (2013) 0.75
Stromal scar in a laser in situ keratomileusis flap after photorefractive keratectomy enhancement: June consultation #1. J Cataract Refract Surg (2017) 0.75
[Effect of subconjunctival bevacizumab on corneal neovascularization and reepithelization 25 days after chemical burn]. Arq Bras Oftalmol (2011) 0.75